astrazeneca oral glp 1 Expands into Obesity with GLP-1 Therapy | Ahmad Hammoud, Pharmacist, One Health Professional posted on the topic AstraZeneca (AZN) Advances Oral GLP-1

Diabetes 66 (5), 12721285

Sean Hashmi, MD, is the regional medical director of Lifestyle & Obesity Medicine for the Southern California Permanente Medical Group, and national chair of the interregional clinical practice group for Lifestyle & Obesity Medicine, The Permanente Federation.

Yes, it is always important to consult with your primary care practitioner before beginning a supplement routine, and it is even more important to do so if you are on prescription medications

The main considerations for eligibility will be your overall health, whether the condition for which you are taking the medication (e.g., type 2 diabetes or obesity) is well-managed, and if you are experiencing any acute side effects on the day of donation that could make the process unsafe

Reasonable Consumer Standard: This article is written for a general adult consumer audience

The AGA specifically suggests continuation of GLP1-RA use until the day or a week prior to the procedure for daily or weekly GLP1-RAs, respectively [195]